Related Business Topics
Latest Headlines
Reuters - Nov. 19, 2009, 2:59 PM
* ImmunoGen to get $1 mln upfront payment * Up to $34 mln in milestone payments Nov 19 (Reuters) - Drugmaker ImmunoGen Inc (IMGN.O) said it licensed its technology to develop anti-cancer drugs to Amgen Inc (AMGN.O) for a $1 million upfront payment. ...
Forbes.com - Nov. 19, 2009, 2:47 PM
* ImmunoGen to get $1 mln upfront payment * Up to $34 mln in milestone payments Nov 19 (Reuters) - Drugmaker ImmunoGen Inc ImmunoGen is also entitled to receive milestone payments of up to $34 million and royalties on the sale of any resulting products. ...
Reuters - Nov. 17, 2009, 10:24 AM
WALTHAM, Mass.--(Business Wire)-- ImmunoGen, Inc. (Nasdaq: IMGN), a biopharmaceutical company that develops targeted anticancer therapeutics, today reported encouraging clinical data with its IMGN901 product candidate in the treatment of Merkel cell ...
CNBC - Nov. 17, 2009, 9:44 AM
Forbes.com - Oct. 27, 2009, 4:06 AM
BusinessWire - ImmunoGen, Inc. (Nasdaq: IMGN), a biotechnology company that develops targeted anticancer products, today announced that its presentation at the Oppenheimer 20th Annual Healthcare Conference will be webcast live. The presentation is ...
Forbes.com - Oct. 22, 2009, 3:59 AM
BusinessWire - ImmunoGen, Inc. (Nasdaq:IMGN), a biotechnology company that develops targeted anticancer products, today announced that will host a conference call at 4:30 pm ET on Thursday, October 29, 2009 to discuss the Company's financial results for ...
0-9 |
A |
B |
C |
D |
E |
F |
G |
H |
I |
J |
K |
L |
M |
N |
O |
P |
Q |
R |
S |
T |
U |
V |
W |
X |
Y |
Z
I
